- Home
- BALY vs STTK Comparison
BALY vs STTK Comparison
Compare BALY & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BALY | STTK |
|---|---|---|
| Founded | 2004 | 2016 |
| Country | United States | United States |
| Employees | 11700 | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 711.1M | 652.4M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BALY | STTK |
|---|---|---|
| Price | $13.51 | $5.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 12 |
| Target Price | $9.67 | ★ $15.40 |
| AVG Volume (30 Days) | 76.1K | ★ 1.1M |
| Earning Date | 11-09-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.37 | ★ 53.02 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,436,189,000.00 | $1,000,000.00 |
| Revenue This Year | $19.09 | N/A |
| Revenue Next Year | $8.08 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.44 | $1.72 |
| 52 Week High | $19.60 | $8.33 |
Technical Indicators
Market Signals| Indicator | BALY | STTK |
|---|---|---|
| Relative Strength Index (RSI) | 54.63 | 41.15 |
| Support Level | $13.38 | $5.19 |
| Resistance Level | $14.20 | $7.66 |
| Average True Range (ATR) | 0.57 | 0.36 |
| MACD | -0.13 | 0.03 |
| Stochastic Oscillator | 52.04 | 27.58 |
Price Performance
Historical ComparisonAbout BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, entertainment, and technology company operating across casino, interactive, and lottery markets. It provides physical and interactive gaming experiences, including casino gaming, iGaming, sportsbook, online bingo, free-to-play games, and technology-driven lottery solutions. The company's segments include Casinos & Resorts, which generates maximum revenue and operates casino and resort properties, a horse racetrack, and a golf course; Bally's Intralot B2B, which provides lottery and technology services; Bally's Intralot B2C, which includes interactive gaming and lottery operations, including a UK casino; and North America Interactive, which includes sports betting and iGaming operations in the United States and Canada.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.